Trial of COVID-19's new Treatment Method starting soon According to scientists, people with the highest severity of the disease have a very small number of immune cells called T cells, which are used to fight infections in the body. Scientists in the UK are set to test a treatment they hope will improve the health of even the most severely affected by COVID-19. Scientists have found that people with the highest severity of the disease have a much lower number of immune cells called T cells. T-Cells or T lymphocytes T cells (also called T lymphocytes) are one of the major components of the adaptive immune system . Their roles include directly killing infected host cells, activating other immune cells, producing cytokines and regulating the immune response . This clinical trial will test whether a drug called interleukin 7, which increases the number of T cells, can help patients recover. The study involved scientists from the Francis Creek Institute, King&
News and facts related to science of space,health ,medicine, physics, chemistry, biology, astronomy, geography, computer,artificial intelligence, mathematics, technology,everyday science, biotechnology, genetic engineering, psychology, human emotions,history and interesting news related all sciences and everyday life. I will hope my best to share authentic and neutral content related to the topics mentioned above.